Inventor
NANJAPPAN PALANIAPPA
US34 patents
⚠️ This page may combine multiple inventors who share the name “NANJAPPAN PALANIAPPA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRACCO SUISSE SA
8 patentsUS9056138B2Jun 16, 2015
Multivalent constructs for therapeutic and diagnostic applications
BRACCO SUISSE SA11 citations92
US7910088B2Mar 22, 2011
Multivalent constructs for therapeutic and diagnostic applications
BRACCO SUISSE SA24 citations92
US7854919B2Dec 21, 2010
Multivalent constructs for therapeutic and diagnostic applications
BRACCO SUISSE SA20 citations92
US7884183B2Feb 8, 2011
Compounds for targeting endothelial cells, compositions containing the same and methods for their use
BRACCO SUISSE SA11 citations84
US7985402B2Jul 26, 2011
Targeting vector-phospholipid conjugates
BRACCO SUISSE SA14 citations83
US9381258B2Jul 5, 2016
Targeting vector-phospholipid conjugates
BRACCO SUISSE SA2 citations62
US9295737B2Mar 29, 2016
Targeting vector-phospholipid conjugates
BRACCO SUISSE SA1 citations62
US9408926B2Aug 9, 2016
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
BRACCO SUISSE SA0 citations51
BRACCO INT BV
7 patentsUS7109167B2Sep 19, 2006
Compounds for targeting endothelial cells, compositions containing the same and methods for their use
BRACCO INT BV37 citations96
US7794693B2Sep 14, 2010
Targeting vector-phospholipid conjugates
BRACCO INT BV19 citations92
US7666979B2Feb 23, 2010
Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
BRACCO INT BV29 citations92
US5651954AJul 29, 1997
Method of using hydrazone containing ligands and metal complexes thereof
BRACCO INT BV7 citations74
US7820621B2Oct 26, 2010
Compounds for targeting endothelial cells, compositions containing the same and methods for their use
BRACCO INT BV3 citations63
US6660246B1Dec 9, 2003
Ligands and metal complexes thereof
BRACCO INT BV4 citations63
US5663307ASep 2, 1997
Hydrazone containing ligands and metal complexes thereof
BRACCO INT BV2 citations63
DYAX CORP
4 patentsUS8044175B2Oct 25, 2011
Peptides that specifically bind HGF receptor (CMET) and uses thereof
DYAX CORP44 citations98
US7261876B2Aug 28, 2007
Multivalent constructs for therapeutic and diagnostic applications
DYAX CORP33 citations96
US7211240B2May 1, 2007
Multivalent constructs for therapeutic and diagnostic applications
DYAX CORP52 citations95
US9446155B2Sep 20, 2016
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
DYAX CORP0 citations51
BRACCO IMAGING SPA
4 patentsUS7850947B2Dec 14, 2010
Gastrin releasing peptide compounds
BRACCO IMAGING SPA18 citations92
US7611692B2Nov 3, 2009
Gastrin releasing peptide compounds
BRACCO IMAGING SPA21 citations92
US7226577B2Jun 5, 2007
Gastrin releasing peptide compounds
BRACCO IMAGING SPA35 citations92
US7922998B2Apr 12, 2011
Gastrin releasing peptide compounds
BRACCO IMAGING SPA12 citations83
CAPPELLETTI ENRICO
4 patentsUS8444954B2May 21, 2013
Gastrin releasing peptide compounds
CAPPELLETTI ENRICO9 citations82
US8420050B2Apr 16, 2013
Gastrin releasing peptide compounds
CAPPELLETTI ENRICO10 citations82
US8414864B2Apr 9, 2013
Gastrin releasing peptide compounds
CAPPELLETTI ENRICO5 citations82
US8420053B2Apr 16, 2013
Gastrin releasing peptide compounds
CAPPELLETTI ENRICO1 citations51